This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Zydelig
  • /
  • A Phase 2, Open-Label Study Evaluating the Efficac...
Clinical trial

A Phase 2, Open-Label Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacodynamics of GS-9973 in Combination With Idelalisib in Subjects With Relapsed or Refractory Hematologic Malignancies

Read time: 2 mins
Last updated:1st Jun 2013
Identifier: NCT01796470
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest